MDMA-assisted therapy may provide lasting benefit for patients with MDD. Seven-month follow-up shows sustained symptom ...

For millions of people living with major depressive disorder, finding an effective treatment can feel like a never-ending ...

Preclinical research showed that DMT antidepressant effects were rapid and robust in a stress-based depression model. Find ...

The American College of Lifestyle Medicine has published a new expert consensus statement affirming evidence-based lifestyle interventions as foundational, primary, and adjunctive treatments for major ...

In a review published in Nature Reviews Rheumatology, researchers discussed the interactions between central and peripheral immunobiological mechanisms associated with rheumatoid arthritis (RA) and ...

Johnson & Johnson’s oral add-on drug significantly improved depressive symptoms and sleep outcomes in a phase 3 trial for patients who previously did not benefit from antidepressants alone. The ...

Rates of depression notably spiked during the pandemic. But even though life has largely returned to normal, we’re still in a mental health crisis. In 2023, the U.S. Surgeon General declared an ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks ...

A new update, led by researchers at the UNC School of Medicine and the Gillings School of Global Public Health, describes major findings from the past half decade in the realm of psychiatric genomics ...

Depression and seasonal affective disorder (SAD) share similar symptoms, but depression can occur at any time of the year, while SAD follows a recurring seasonal pattern. For a SAD diagnosis, a person ...